| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details) - Supplier Concentration Risk - Vendor One | 3 Months Ended | 12 Months Ended | |
|---|---|---|---|
| Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
| Research and development expenditures | |||
| Concentration | |||
| Concentration Risk (as a percent) | 60.00% | 49.00% | |
| Accounts payable and accrued expense | |||
| Concentration | |||
| Concentration Risk (as a percent) | 82.00% | 56.00% | |
| X | ||||||||||
| 
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available. 
 | 
| X | ||||||||||
| 
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 |